Refine Your Results

Click below to filter your search results

"Guidelines"Undo

Search Results

Return to List
Results 201–220 of 224
Sort By: Relevance | Date | Title
201.

The Initial Reproductive Health Visit

Committee Opinion Number 598, May 2014

(Replaces Committee Opinion Number 460, July 2010)

ABSTRACT The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years The initial reproductive health visit provides an excellent opportunity for the obstetriciangynecologist to start a pa...

May 2014

PDF Format
202.

The Limits of Conscientious Refusal in Reproductive Medicine

Committee Opinion Number 385, November 2007

Reaffirmed 2016

ABSTRACT Health care providers occasionally may find that providing indicated even standard care would present for them a personal moral problema conflict of conscienceparticularly in the field of reproductive medicine Although respect for conscience is important conscientious refusals should be l...

November 2007

PDF Format
203.

The Obstetric and Gynecologic Hospitalist

Committee Opinion Number 657, February 2016

(Replaces Committee Opinion Number 459, July 2010)

ABSTRACT The term hospitalist refers to physicians whose primary professional focus is the general medical care of hospitalized patients Their activities may include patient care teaching research and inpatient leadership The American College of Obstetricians and Gynecologists supports the continu...

February 2016

PDF Format
204.

The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer

Committee Opinion Number 477, March 2011

(Replaces No. 280, December 2002)

ABSTRACT Epithelial ovarian cancer is most commonly detected in an advanced stage when the overall 5year survival rate is 2030 Detection of earlystage ovarian cancer results in improved survival Currently there is no effective strategy for ovarian cancer screening Women with persistent and progres...

March 2011

PDF Format
205.

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Committee Opinion Number 440, August 2009

(Reaffirmed 2015)

ABSTRACT The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography this initial evaluation does not require p...

August 2009

PDF Format
206.

The Transition From Pediatric to Adult Health Care: Preventive Care for Young Women Aged 18-26 Years

Committee Opinion Number 626, March 2015

ABSTRACT Young women aged 1826 years are a heterogeneous population transitioning from adolescence into adulthood who may present with unique issues and challenges including a potential gap in health care after pediatric health care Obstetriciangynecologists should note that these patients may nee...

March 2015

PDF Format
207.

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis

Committee Opinion Number 581, December 2013

(Replaces No. 446, November 2009. Reaffirmed 2015)
(See also Practice Bulletin No. 88)

ABSTRACT Chromosomal microarray analysis is a technique that identifies chromosomal abnormalities including submicroscopic abnormalities that are too small to be detected by conventional karyotyping Like conventional fetal karyotyping prenatal chromosomal microarray analysis requires direct testin...

December 2013

PDF Format
208.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Committee Opinion Number 659, March 2016

ABSTRACT Cancer treatment should address femalespecific survivorship issues including the hypoestrogenicrelated adverse effects of cancer therapies or of natural menopause in survivors Systemic and vaginal estrogen are widely used for symptomatic relief of vasomotor symptoms sexual dysfunction and...

March 2016

PDF Format
209.

Timing of Umbilical Cord Clamping After Birth

Committee Opinion Number 543, December 2012

(Reaffirmed 2014)

ABSTRACT The optimal timing for clamping the umbilical cord after birth has been a subject of controversy and debate Although many randomized controlled trials in term and preterm infants have evaluated the benefits of delayed umbilical cord clamping versus immediate umbilical cord clamping the id...

December 2012

PDF Format
210.

Tobacco Use and Women's Health

Committee Opinion Number 503, September 2011

(Reaffirmed 2015)

ABSTRACT Tobacco use negatively affects every organ system and is the most prevalent cause of premature death for adults within the United States Compared with women who are nonsmokers women who smoke cigarettes have greater risks of reproductive health problems many forms of gynecologic cancer an...

September 2011

PDF Format
211.

Tracking and Reminder Systems

Committee Opinion Number 546, December 2012

(Reaffirmed 2014, Replaces No. 461, August 2010)

ABSTRACT An accurate and effective tracking or reminder system is useful for the modern practice of obstetrics and gynecology Practices should not rely solely on the patient to complete all ordered studies and to follow up on health care provider recommendations Health care providers should encour...

December 2012

PDF Format
212.

Tubal Ligation with Cesarean Delivery

Committee Opinion Number 205, August 1998

Tubal ligation at the time of cesarean delivery requires significant additional physician work even though the technical work of the procedure is brief Informed consent by the patient requires considerably more counseling by the physician regarding potential risks and benefits of this procedure th...

August 1998

PDF Format
213.

Umbilical Cord Blood Banking

Committee Opinion Number 648, December 2015

(Replaces Committee Opinion Number 399, February 2008)

ABSTRACT Once considered a waste product that was discarded with the placenta umbilical cord blood is now known to contain potentially lifesaving hematopoietic stem cells When used in hematopoietic stem cell transplantation umbilical cord blood offers several distinct advantages over bone marrow o...

December 2015

PDF Format
214.

Understanding and Using the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010

Committee Opinion Number 505, September 2011

(Reaffirmed 2014)

ABSTRACT The 2010 US Medical Eligibility Criteria for Contraceptive Use US MEC issued by the Centers for Disease Control and Prevention gives comprehensive evidencebased guidance to clinicians providing family planning services to women especially women with medical conditions The American College...

September 2011

PDF Format
215.

Understanding and Using the U.S. Selected Practice Recommendations for Contraceptive Use, 2013

Committee Opinion Number 577, November 2013

(Reaffirmed 2015)

ABSTRACT The US Selected Practice Recommendations for Contraceptive Use 2013 US SPR issued by the Centers for Disease Control and Prevention is a companion piece to the Centers for Disease Control and Preventions US Medical Eligibility Criteria for Contraceptive Use 2010 The US Medical Eligibility...

November 2013

PDF Format
216.

Update on Carrier Screening for Cystic Fibrosis

Committee Opinion Number 486, April 2011

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format
217.

Update on Immunization and Pregnancy Tetanus Diphtheria and Pertussis Vaccination

Committee Opinion Number 566, June 2013

(Replaces No. 521, March 2012, Reaffirmed 2015)

ABSTRACT In the face of dramatic and persistent increases in pertussis disease in the United States the Centers for Disease Control and Preventions Advisory Committee on Immunization Practices has updated its guidelines for the use of the tetanus toxoid reduced diphtheria toxoid and acellular pert...

June 2013

PDF Format
218.

Using Preimplantation Embryos for Research

Committee Opinion Number 347, November 2006

(Reaffirmed 2008)

ABSTRACT Human embryonic stem cell research promises an increased understanding of the molecular process underlying cell differentiation Transplantation of embryonic stem cells or their derivatives may in the future offer therapies for human diseases In this Committee Opinion the American College ...

November 2006

PDF Format
219.

Vaginal Placement of Synthetic Mesh for Pelvic Organ Prolapse

Committee Opinion Number 513, December 2011

(Reaffirmed 2015)

ABSTRACT Since 2004 use of synthetic mesh has increased in vaginal surgery for the treatment of pelvic organ prolapse However concerns exist about the safety and efficacy of transvaginally placed mesh Based on the currently available limited data although many patients undergoing meshaugmented vag...

December 2011

PDF Format
220.

Vaginal "Rejuvenation" and Cosmetic Vaginal Procedures

Committee Opinion Number 378, September 2007

(Reaffirmed 2014)

ABSTRACT Socalled vaginal rejuvenation designer vaginoplasty revirgination and Gspot amplification are vaginal surgical procedures being offered by some practitioners These procedures are not medically indicated and the safety and effectiveness of these procedures have not been documented Clinicia...

September 2007

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998